Bioethics for clinicians: 10. Research ethics

CMAJ. Canadian Medical Association Journal

Volumn 156, Issue 8, 1997, Pages 1153-1157

  Weijer, Charles ^a,b,e   Dickens, Bernard ^a   Meslin, Eric M ^c,d  

^a at the University of Toronto Wagner is also a faculty member of the Canadian Medical Associations' Physician Management Institute   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; INFORMED CONSENT; JUSTICE; LAW; MEDICAL ETHICS; MEDICAL RESEARCH; POLICY; RESPONSIBILITY; SHORT SURVEY;

EID: 0030927753     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (44)

1. Hellman S, Hellman D. Of mice but not men: problems of the randomized clinical trial. N Engl J Med 1991;324:1584-9.
2. Weijer C. The breast cancer research scandal: addressing the issues. Can Med Assoc J 1995;152:1195-7.
3. Elliott C, Weijer C. Cruel and unusual treatment. Saturday Night 1995;110 (10):31-4.
4. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. OPRR [Office for Protection from Research Risks] Reports; 1979(Apr 18):1-8.
5. Levine RJ. Ethics and regulation of clinical research. New Haven (CT): Yale University Press; 1988:95-153.
6. Levine RJ. Ethics and regulation of clinical research. New Haven (CT): Yale University Press; 1988:37-65.
7. Levine RJ. Ethics and regulation of clinical research. New Haven (CT): Yale University Press; 1988:67-93.
8. Meslin EM, Sutherland HJ, Lavery JV, Till JE. Principlism and the ethical appraisal of clinical trials. Bioethics 1995;9:399-418.
9. Freedman B. Scientific value and validity as ethical requirements for research: a proposed explanation. IRB: Rev Hum Subj Res 1987;17(6):7-10.
10. Sutherland HJ, Meslin EM, Till JE. What's missing from current clinical trials guidelines? A framework for integrating science, ethics and the community. J Clin Ethics 1994;5:297-303.
11. Weijer C, Shapiro S, Fuks A, Glass KC, Skrutkowska M. Monitoring clinical research: an obligation unfulfilled. Can Med Assoc J 1995;152:1973-80.
12. World Medical Association. Declaration of Helsinki, [1964, rev 1975, 1983, 1989]. In: Reich WT, editor. Encyclopedia of bioethics. rev ed. New York: Simon & Schuster MacMillan; 1995:2765-7.
13. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Can Med Assoc J 1997; 156:270-7.
14. Meslin EM. Toward an ethic in dissemination of new knowledge in primary care research. In: Dunn EV, editor. Disseminating research/changing practice: research methods for primary care, vol 6. Thousand Oaks (CA): Sage Publications; 1994:32-44.
15. Truman v. Thomas (1980), 611 Pacific (2d) 902 (Sup Ct Calif).
16. Dickens BM. Medical records - patient's right to receive copies - physician's fiduciary duty of disclosure: McInerney v. MacDonald. Can Bar Rev 1994; 73:234-42.
17. Deleury E, Croubau D. Le droit des personnes physiques. Cowansville (QC): Éditions Yvon Blais; 1994:119-20.
18. Nuremberg Code [1947]. In: Reich WT, editor. Encyclopedia of boethics. rev ed. New York: Simon & Schuster MacMillan; 1995:2763-4.
19. General Assembly of the United Nations: International covenant on civil and political rights (1958). In: Reich WT, editor. Encyclopedia of bioethics. rev ed. New York: Simon & Schuster MacMillan; 1995:2765.
20. US Department of Health and Human Services. Protection of human subjects [part 46 of Code of federal regulations, title 45 (Public welfare)]. rev 1991 June 18. Washington: The Department; 1991.
21. Council for International Organizations of Medical Sciences. International ethical guidelines far biomedical research involving human subjects. Geneva: The Council; 1993.
22. Council for International Organizations of Medical Sciences. International guidelines for ethical review of epidemiological studies. Geneva: The Council; 1991.
23. Human Genome Organization. Statement on the principled conduct of genetic research. Genome Digest 1996;3(2):2-3.
24. Guidelines on research involving human subjects. Ottawa: Medical Research Council of Canada; 1987.
25. Drugs directorate guidelines: conduct of clinical investigations. Ottawa: Health Protection Branch, Health Canada, 1989.
26. Tri-Council Working Group. Code of conduct for research involving humans [draft document]. Ottawa: Department of Supply and Services; 1996.
27. Reicken HW, Ravich R. Informed consent to biomedical research in Veteran's administration hospitals. JAMA 1982;248:344-50.
28. Appelbaum P, Roth L, Lidz C, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 1987;2:20-4.
29. White House Advisory Committee on Human Radiation Experiments. Final Report [doc no 061-000-00-848-9]. Washington: The Committee; 1995.
30. Silva MC, Sorrell JM. Enhancing comprehension of information for informed consent: a review of empirical research. IRB: Rev Hum Subj Res 1988;10(1):1-5.
31. US Department of Health and Human Services. Protection of human subjects [part 46 of Code of federal regulations, title 45 (Public welfare)]. rev 1991 June 18. Washington: The Department; 1991: 111(a).
32. Levine RJ. The impact of HIV infection on society's perception of clinical trials. Kennedy Inst Ethics J 1994;4:93-8.
33. Weijer C. Evolving ethical issues in selection of subjects for clinical research. Camb Q Healthc Ethics 1996;5:334-45.
34. Boros L, Chuange C, Butler FO, Bennett JM. Leukemia in Rochester: a 17-year experience with an analysis of the role of cooperative group (ECOG [Eastern Cooperative Oncology Group]) participation. Cancer 1985;56:2161-9.
35. Karjalainen S, Palva I. Do treatment protocols improve end results? A study of the survival of patients with multiple myeloma in Finland. BMJ 1989;299: 1069-72.
36. Hjorth M, Holmberg E, Rodler S, Westin J. Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. Br J Haematol 1992;80:55-61.
37. Weijer C, Freedman B, Fuks A, Robbins J, Shapiro S, Skrutkowska M. What difference does it make to be treated in a clinical trial? A pilot study. Clin Invest Med 1996;19:179-83.
38. Freedman B, Shapiro S. Ethics and statistics in clinical research: towards a more comprehensive examination. J Stat Plann Inference 1994;42:223-40.
39. Office for Protection from Research Risk. Protecting human subjects: institutional review board guidebook. Washington: The Office; 1993.
40. Lind SE. Finder's fees for research subjects. N Engl J Med 1990;323:192-5.
41. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987; 317:141-3.
42. Kane JM. Schizophrenia. N Engl J Med 1996;334:34-1.
43. Freedman B, Weijer C, Glass KC. Placebo orthodoxy in clinical research. I: Empirical and methodological myths. J Law Med Ethics 1996;24:243-51.
44. Freedman B, Glass KC, Weijer C. Placebo orthodoxy in clinical research. II: Ethical, legal and regulatory myth. J Law Med Ethics 1996;24:252-3.